Development of an age-specific paediatric 2-[18F]fluoro-2-deoxy-D-glucose PET template aligned with paediatric brain

Huan Ma1, Xin Wen1, Haizhou Qiao2

  • 1Nuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.

Brain Communications
|July 25, 2026
PubMed

Insights

New pediatric brain templates for 2-[18F]fluoro-2-deoxy-D-glucose PET improve epilepsy diagnosis. These age-specific templates enhance the accuracy of localizing the epileptogenic zone in children, outperforming adult templates.

Area of Science:

  • Neuroimaging
  • Nuclear Medicine
  • Pediatric Neurology

Background:

  • Accurate localization of the epileptogenic zone is crucial for treating pediatric drug-resistant epilepsy.
  • Existing neuroimaging templates are primarily based on adult brain development, potentially limiting their accuracy in pediatric populations.
  • Understanding developmental changes in pediatric brain glucose metabolism is essential for improving diagnostic tools.

Purpose of the Study:

  • To systematically analyze brain glucose metabolism development in children across all pediatric age ranges.
  • To establish age-specific pediatric 2-[18F]fluoro-2-deoxy-D-glucose (FDG) PET brain templates.
  • To enhance the accuracy of neuroimaging-based epileptogenic zone localization in pediatric epilepsy.

Main Methods:

  • Retrospective analysis of pseudo-control and epilepsy patient groups using 2-[18F]fluoro-2-deoxy-D-glucose PET data.
  • Calculation of semi-quantitative parameters (SUVmean, SUVmax) and comparison of standardized uptake ratios.
  • Development and validation of age-specific pediatric statistical parametric mapping (SPM) templates.
  • Comparison of diagnostic accuracy for epileptogenic zone localization using pediatric versus adult SPM templates, with surgical resection and ECoG as gold standards.

Main Results:

  • Pediatric brain glucose metabolism (SUVmean, SUVmax) positively correlated with age, with no significant sex or hemispheric differences.
  • The established pediatric SPM template achieved a diagnostic accuracy of 79.0% for epileptogenic zone localization, significantly higher than the adult template (72.5%).
  • The pediatric template demonstrated consistent advantages across sexes and superior performance in localizing frontal and temporal lobe epileptogenic zones.

Conclusions:

  • Age-specific pediatric SPM templates derived from 2-[18F]fluoro-2-deoxy-D-glucose PET data significantly improve the diagnostic efficacy for pediatric drug-resistant epilepsy.
  • These pediatric templates overcome the limitations of adult templates, offering more accurate and reliable preoperative epileptogenic zone localization.
  • The developed pediatric templates provide a valuable tool for neuroimaging in pediatric epilepsy, with stable advantages across demographics and specific brain regions.

Related Concept Videos